BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15327105)

  • 1. The risk of other primary cancer in patients with uveal melanoma: a retrospective cohort study of a Canadian population.
    Callejo SA; Al-Khalifa S; Ozdal PC; Edelstein C; Burnier MN
    Can J Ophthalmol; 2004 Jun; 39(4):397-402. PubMed ID: 15327105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal melanoma: a study on incidence of additional cancers in the Swedish population.
    Bergman L; Nilsson B; Ragnarsson-Olding B; Seregard S
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):72-7. PubMed ID: 16384946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
    Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
    Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal melanoma incidence trends in Canada: a national comprehensive population-based study.
    Ghazawi FM; Darwich R; Le M; Rahme E; Zubarev A; Moreau L; Burnier JV; Sasseville D; Burnier MN; Litvinov IV
    Br J Ophthalmol; 2019 Dec; 103(12):1872-1876. PubMed ID: 30819691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification.
    Stang A; Parkin DM; Ferlay J; Jöckel KH
    Int J Cancer; 2005 Mar; 114(1):114-23. PubMed ID: 15523698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial uveal melanoma. Clinical observations on 56 patients.
    Singh AD; Shields CL; De Potter P; Shields JA; Trock B; Cater J; Pastore D
    Arch Ophthalmol; 1996 Apr; 114(4):392-9. PubMed ID: 8602775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral primary uveal melanoma. Bad luck or bad genes?
    Singh AD; Shields CL; Shields JA; De Potter P
    Ophthalmology; 1996 Feb; 103(2):256-62. PubMed ID: 8594511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other cancers in uveal melanoma patients and their families.
    Turner BJ; Siatkowski RM; Augsburger JJ; Shields JA; Lustbader E; Mastrangelo MJ
    Am J Ophthalmol; 1989 Jun; 107(6):601-8. PubMed ID: 2729409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple neoplasms in patients with uveal melanoma].
    Caminal JM; Martínez J; Arias LL; Rubio M; Pujol O; Roca G; Arruga J
    Arch Soc Esp Oftalmol; 2007 Sep; 82(9):535-40. PubMed ID: 17846942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma.
    Damento GM; Pulido JS; Abbott BA; Hodge DO; Dalvin LA
    Mayo Clin Proc; 2019 Jul; 94(7):1287-1295. PubMed ID: 31272570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
    Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
    Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up.
    Wróblewska-Zierhoffer M; Paprzycka B; Kubiak A; Tomczyk Ł; Rospond-Kubiak I
    BMC Ophthalmol; 2023 Dec; 23(1):506. PubMed ID: 38087265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevalence of bilateral malignant uveal melanoma].
    Sturm V; Richard G
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):770-4. PubMed ID: 17952820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan.
    Zewar A; Nawaiseh I; Jaradat I; Khzouz J; Alrawashdeh K; Abdeen G; Mehyar M; Khurma S; Yousef YA
    Turk Patoloji Derg; 2016; 32(3):186-92. PubMed ID: 27562393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of other primary tumours in patients with oral cancer in Scotland.
    Crosher R; McIlroy R
    Br J Oral Maxillofac Surg; 1998 Feb; 36(1):58-62. PubMed ID: 9578260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
    Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the influence of one's education on early diagnosis of multiple primary cancer in patients with uveal melanoma.
    Mierzwa-Dobranowska M; Romanowska-Dixon B
    Klin Oczna; 2012; 114(2):111-4. PubMed ID: 23346797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.